Posts

cliexaRA Press Release

cliexa® partners with the Colorado Arthritis Center to identify how screening and monitoring of Rheumatoid Arthritis patients through a customized electronic platform, cliexa-RA, impacts clinical efficiency.

See the full press release from PR.com: //www.pr.com/press-release/765307

Download the Case Study here: //www.cliexa.com/cliexa-ra-case-study/

Learn more about cliexa-RA: //www.cliexa.com/cliexamobile/rheumatoid-arthritis/

cliexa at Health:Further 2018

On August 27-29, members of the cliexa team, including founder and CEO Mehmet Kazgan, will be attending the Health:Further Conference in Nashville, TN.

The cliexa booth will be in Entrepreneur’s Alley to demo our platforms, and solutions. Angie Buckley, our Director of Business Development, and Ashley Darnell, our Product Manager, are experts at everything cliexa, and will be there everyday. Don’t be shy, come say hello!

This annual healthcare innovation conference is expected to bring in over 2,000 attendees from various healthcare companies, start-ups, and many investors. Health:Further was started in 2015 by Jumpstart Foundry, who selected cliexa as one of their 2018 portfolio companies. cliexa will be accompanied by other avant-garde companies at the conference, such as Vend.RX, Doc&I, LevelTherapy, and more!

If you are attending the conference, we’d love to meet you, and help you learn more about what we do! Find us on the Health:Further mobile app, and reach out to us through direct message. Our team will be available to answer questions. If you cannot find us at the conference, or will not be attending and still want to learn more about what we do, please feel free to contact us! Hope to see you there!

STDs are a persistent enemy
STDs are a persistent enemy

…Jonathan Mermin, director of the CDC’s National Center for STDs and TB Prevention, said in a news release last month. He added that the epidemic is, “…growing in number, and outpacing our ability to respond.” Over 50% of new cases of STDs occur in young people ages 15 – 24, Chlamydia cases the most prominent. Front-line defense–primary care clinics and overloaded physicians. They may feel they do not get honest answers or they don’t have time to ask difficult questions. Young people are not comfortable with face-to-face discussions about reproductive health.

Some physicians don’t know how to broach this sensitive conversation, “This is an awkward topic, especially for men and they avoid having these conversations. cliexa-OPTIONS gives male physicians and clinicians a tool to get through the awkwardness …This epidemic impacts females more because they are left holding the bag.”   So is it a lost cause? No, digital health offers promising solutions.

Why is Primary Care so Important?

Leveraging long-standing relationships with pediatricians and family physicians–an underutilized strategy on the front lines of this devastating battle, helps youth stay healthy. Young people respond to authentic conversations with people they know and trust.  Primary care screenings identify most new cases of Chlamydia. That’s where the cliexa-OPTIONS App, an innovative digital health technology,  plays a crucial role.

cliexa-OPTIONS reduces the cognitive load for clinicians by creating a structured report using our unique scoring algorithm. Our measures are more sensitive to cultural trends young people experience. Three levels of high risk allow tailored, pinpointed conversations that count. Our recent clinical pilot confirmed the benefits of the OPTIONS App.

Risk assessment quality was average before piloting the cliexa-OPTIONS App. After implementing cliexa-OPTIONS, physicians rated the quality of their sexual risk assessment as excellent. The cliexa-OPTIONS App improves reproductive health counseling by “making it easier for my patients to discuss what is REALLY going on with them.” Physicians said the App saves them time and all participants reported that cliexa-OPTIONS supports early identification of youth at highest risk of acquiring an STD.

Positive ROI increases revenue improves quality, tracks efforts, and supports better outcomes for young people. What’s not to love about the cliexa-OPTIONS App?? To find out how to get started, contact the cliexa team.

The Rocky Mountain Life Science Investor & Partnering Conference(RMLIPC) will bring together leading investors and strategic partners from across the U.S. and the region’s top life science companies to cultivate partnerships and source investment opportunities in the areas of medical device, diagnostic, biotech, pharma and digital health.

The Rocky Mountain region is the largest and most advanced area between both coasts, with over $1.9 billion in investment in the region between 2011-2016.

cliexa is selected as one of the presenting companies by Colorado BioScience Association‘s at Rocky Mountain Life Science Investor and Partnering Conference.

cliexa was one of the sponsors and exhibitors at University of Colorado Anschutz Medical Center Postdoctoral Research Day.

Keynote speaker was Jennifer Kahn. Jennifer Kahn is a science journalist and contributing writer for the New York Times Magazine, and has been regularly featured on The New Yorker, National Geographic, Wired, and Outside, among others. Her work has been selected for the Best American Science Writing series four times, and is also featured in the anthology Best American Sports Writing.

​​This year’s career development discussion featured a panel of speakers from six different career areas in one room to compare and contrast how each scientist got to their current position and what advice they have for current postdocs.

Interns Jeff Mutchnik and Emma Schmitt, discussed with post-docs and other vendors about innovations in health care.